1 - 25 of 35 results for author:"Polyak K." in Literature citations
Results Customize
› Repeat search in UniProtKB (19)
| Evolutionary pathways in BRCA1-associated breast tumors. Martins F.C., De S., Almendro V., Gonen M., Park S.Y., Blum J.L., Herlihy W., Ethington G., Schnitt S.J., Tung N. et al. Cancer Discov 2:503-511(2012) · Mapped (35) |
| Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers. Jiao X., Wood L.D., Lindman M., Jones S., Buckhaults P., Polyak K., Sukumar S., Carter H., Kim D., Karchin R. et al. Genes Chromosomes Cancer 51:480-489(2012) · Mapped (7) |
| The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium. Balko J.M., Miller T.W., Morrison M.M., Hutchinson K., Young C., Rinehart C., Sanchez V., Jee D., Polyak K., Prat A. et al. Proc. Natl. Acad. Sci. U.S.A. 109:221-226(2012) · Mapped (2) |
| PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Shrestha Y., Schafer E.J., Boehm J.S., Thomas S.R., He F., Du J., Wang S., Barretina J., Weir B.A., Zhao J.J. et al. Oncogene 31:3397-3408(2012) · Mapped (27) |
| The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. Marotta L.L., Almendro V., Marusyk A., Shipitsin M., Schemme J., Walker S.R., Bloushtain-Qimron N., Kim J.J., Choudhury S.A., Maruyama R. et al. J. Clin. Invest. 121:2723-2735(2011) · Mapped (21) |
| PIK3CA mutations in in situ and invasive breast carcinomas. Miron A., Varadi M., Carrasco D., Li H., Luongo L., Kim H.J., Park S.Y., Cho E.Y., Lewis G., Kehoe S. et al. Cancer Res. 70:5674-5678(2010) · Mapped (7) |
| Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations. Lauring J., Cosgrove D.P., Fontana S., Gustin J.P., Konishi H., Abukhdeir A.M., Garay J.P., Mohseni M., Wang G.M., Higgins M.J. et al. Oncogene 29:2337-2345(2010) · Mapped (12) |
| Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Zhang Q., Gu J., Li L., Liu J., Luo B., Cheung H.W., Boehm J.S., Ni M., Geisen C., Root D.E. et al. Cancer Cell 16:413-424(2009) · Mapped (13) |
| Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies. Snyder E.L., Bailey D., Shipitsin M., Polyak K., Loda M. Lab. Invest. 89:857-866(2009) · Mapped (6) |
| Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9. Cao D., Polyak K., Halushka M.K., Nassar H., Kouprina N., Iacobuzio-Donahue C., Wu X., Sukumar S., Hicks J., De Marzo A. et al. Breast Cancer Res. 10:R91-R91(2008) · Mapped (11) |
| Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Kleer C.G., Bloushtain-Qimron N., Chen Y.H., Carrasco D., Hu M., Yao J., Kraeft S.K., Collins L.C., Sabel M.S., Argani P. et al. Clin. Cancer Res. 14:5357-5367(2008) · Mapped (4) |
| S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation. Paruchuri V., Prasad A., McHugh K., Bhat H.K., Polyak K., Ganju R.K. PLoS ONE 3:e1741-e1741(2008) · Mapped (1) |
| Cyclooxygenase-2 expression during immortalization and breast cancer progression. Zhao X., Goswami M., Pokhriyal N., Ma H., Du H., Yao J., Victor T.A., Polyak K., Sturgis C.D., Band H. et al. Cancer Res. 68:467-475(2008) · Mapped (7) |
| Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Boehm J.S., Zhao J.J., Yao J., Kim S.Y., Firestein R., Dunn I.F., Sjostrom S.K., Garraway L.A., Weremowicz S., Richardson A.L. et al. Cell 129:1065-1079(2007) · Mapped (1) |
| A putative role for psoriasin in breast tumor progression. Krop I., Marz A., Carlsson H., Li X., Bloushtain-Qimron N., Hu M., Gelman R., Sabel M.S., Schnitt S., Ramaswamy S. et al. Cancer Res. 65:11326-11334(2005) · Mapped (1) |
| HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Krop I., Parker M.T., Bloushtain-Qimron N., Porter D., Gelman R., Sasaki H., Maurer M., Terry M.B., Parsons R., Polyak K. Cancer Res. 65:9659-9669(2005) · Mapped (1) |
| Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants. Carlsson H., Yhr M., Petersson S., Collins N., Polyak K., Enerback C. Cancer Biol. Ther. 4:998-1005(2005) |
| Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Krop I., Player A., Tablante A., Taylor-Parker M., Lahti-Domenici J., Fukuoka J., Batra S.K., Papadopoulos N., Richards W.G., Sugarbaker D.J. et al. Mol. Cancer Res. 2:489-494(2004) · Mapped (1) |
| Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Mehrotra J., Vali M., McVeigh M., Kominsky S.L., Fackler M.J., Lahti-Domenici J., Polyak K., Sacchi N., Garrett-Mayer E., Argani P. et al. Clin. Cancer Res. 10:3104-3109(2004) · Mapped (2) |
| Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Mehrotra J., Ganpat M.M., Kanaan Y., Fackler M.J., McVeigh M., Lahti-Domenici J., Polyak K., Argani P., Naab T., Garrett E. et al. Clin. Cancer Res. 10:2052-2057(2004) · Mapped (58) |
| DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Fackler M.J., McVeigh M., Evron E., Garrett E., Mehrotra J., Polyak K., Sukumar S., Argani P. Int. J. Cancer 107:970-975(2003) · Mapped (16) |
| Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. Krop I., Maguire P., Lahti-Domenici J., Lodeiro G., Richardson A., Johannsdottir H.K., Nevanlinna H., Borg A., Gelman R., Barkardottir R.B. et al. Cancer Res. 63:2024-2027(2003) · Mapped (1) |
| Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues. Porter D., Lahti-Domenici J., Torres-Arzayus M., Chin L., Polyak K. Mech. Dev. 114:201-204(2002) · Mapped (9) |
| Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Seth P., Krop I., Porter D., Polyak K. Oncogene 21:836-843(2002) · UniProtKB (1) |
| Psoriasin expression in mammary epithelial cells in vitro and in vivo. Enerback C., Porter D.A., Seth P., Sgroi D., Gaudet J., Weremowicz S., Morton C.C., Schnitt S., Pitts R.L., Stampl J. et al. Cancer Res. 62:43-47(2002) |